These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37533351)

  • 1. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
    Becerra-Aparicio F; Gómez-Zorrilla S; Hernández-García M; Gijón D; Siverio A; Berbel D; Sánchez-Carrillo C; Cercenado E; Rivera A; de Malet A; Xercavins M; Ruiz de Gopegui E; Canoura-Fernández L; Martínez JA; Seral C; Del Pozo JL; Cotarelo M; Díaz-Regañón J; Cantón R; Oliver A; Horcajada JP; Ruiz-Garbajosa P
    J Antimicrob Chemother; 2023 Sep; 78(9):2291-2296. PubMed ID: 37533351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
    Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Prevalence of ST131 Subclades C2-
    Flament-Simon SC; García V; Duprilot M; Mayer N; Alonso MP; García-Meniño I; Blanco JE; Blanco M; Nicolas-Chanoine MH; Blanco J
    Front Cell Infect Microbiol; 2020; 10():125. PubMed ID: 32266173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe.
    Merino I; Hernández-García M; Turrientes MC; Pérez-Viso B; López-Fresneña N; Diaz-Agero C; Maechler F; Fankhauser-Rodriguez C; Kola A; Schrenzel J; Harbarth S; Bonten M; Gastmeier P; Canton R; Ruiz-Garbajosa P;
    J Antimicrob Chemother; 2018 Nov; 73(11):2973-2980. PubMed ID: 30124851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
    Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
    mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.
    Sauget M; Cholley P; Vannier A; Thouverez M; Nicolas-Chanoine MH; Hocquet D; Bertrand X
    Int J Antimicrob Agents; 2016 Dec; 48(6):744-747. PubMed ID: 27836379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic.
    Matsumura Y; Johnson JR; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S; ;
    J Antimicrob Chemother; 2015; 70(6):1639-49. PubMed ID: 25687644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population snapshot of the extended-spectrum β-lactamase-producing Escherichia coli invasive strains isolated from a Hungarian hospital.
    Tóth K; Tóth Á; Kamotsay K; Németh V; Szabó D
    Ann Clin Microbiol Antimicrob; 2022 Feb; 21(1):3. PubMed ID: 35144632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and virulence of Escherichia coli O16:H5-ST131: comparison with H30 and H30-Rx subclones of O25b:H4-ST131.
    Dahbi G; Mora A; Mamani R; López C; Alonso MP; Marzoa J; Blanco M; Herrera A; Viso S; García-Garrote F; Tchesnokova V; Billig M; de la Cruz F; de Toro M; González-López JJ; Prats G; Chaves F; Martínez-Martínez L; López-Cerezo L; Denamur E; Blanco J
    Int J Med Microbiol; 2014 Nov; 304(8):1247-57. PubMed ID: 25455219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study.
    Birgy A; Levy C; Nicolas-Chanoine MH; Cointe A; Hobson CA; Magnan M; Bechet S; Bidet P; Cohen R; Bonacorsi S
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risks factors associated with ESBL-producing faecal carriage in a single long-term-care facility in Spain: emergence of CTX-M-24- and CTX-M-27-producing Escherichia coli ST131-H30R.
    Colmenarejo C; Hernández-García M; Muñoz-Rodríguez JR; Huertas N; Navarro FJ; Mateo AB; Pellejero EM; Illescas S; Vidal MD; Del Campo R
    J Antimicrob Chemother; 2020 Sep; 75(9):2480-2484. PubMed ID: 32542354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in human intestinal carriage of ESBL- and carbapenemase-producing Enterobacterales among food handlers in Tunisia: emergence of C1-M27-ST131 subclades, blaOXA-48 and blaNDM.
    Sallem N; Hammami A; Mnif B
    J Antimicrob Chemother; 2022 Jul; 77(8):2142-2152. PubMed ID: 35640660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
    Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
    Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of diversity in carbapenemase-producing
    Ellaby N; Doumith M; Hopkins KL; Woodford N; Ellington MJ
    Euro Surveill; 2019 Sep; 24(37):. PubMed ID: 31530344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.